Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ASPIRE: Adult SPasticity International REgistry on BOTOX Treatment

Next Previous
Trial Profile

ASPIRE: Adult SPasticity International REgistry on BOTOX Treatment

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity; Paresis
  • Focus Therapeutic Use
  • Acronyms ASPIRE
  • Sponsors AbbVie; Allergan

    • Most Recent Events

    • 27 Apr 2023 Subgroup post hoc analysis results presented at the 75th Annual Meeting of the American Academy of Neurology 2023.
    • 18 Sep 2022 Results of subset of patients who are naive to botulinum toxins for spasticity presented at the 26th International Congress of Parkinson's Disease and Movement Disorders
    • 18 Sep 2022 Results of sub-group post-hoc analysis assessing treatment utilization for pronated forearm and intrinsic plus hand postures in patients with upper limb spasticity presented at the 26th International Congress of Parkinson's Disease and Movement Disorders
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top